OnKure Therapeutics, Inc. OKUR Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$58.75M+1.3% | -$59.52M+6.2% | -$63.46M-5.2% | -$60.31M-2.1% | -$59.06M-12.1% | ||
| $433K-3.1% | $447K-2.6% | $459K-1.3% | $465K+0.4% | $463K+0.9% | ||
| $11.67M+0.3% | $11.63M+4.4% | $11.15M+34.9% | $8.26M+15.3% | $7.17M+58.2% | ||
| -$50.76M+2.1% | -$51.83M+18.6% | -$63.67M-3.9% | -$61.29M-12.5% | -$54.49M-6.6% | ||
| $33K-28.3% | $46K-11.5% | $52K-18.8% | $64K+4.9% | $61K+17.3% | ||
| -$33K+28.3% | -$46K-100% | $15.87M+0.1% | $15.86M0.0% | $15.86M-0.1% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $116.04M-0.1% | ||
| $95.45M+285% | -$51.71M-183% | $62.37M-3.7% | $64.74M-16.4% | $77.41M-4.3% | ||
| -$50.79M+2.1% | -$51.87M+18.6% | -$63.72M-3.9% | -$61.36M-12.5% | -$54.55M-6.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does OnKure Therapeutics, Inc. generate?
- OnKure Therapeutics, Inc. (OKUR) generated -$50.8M in operating cash flow over the trailing twelve months.
- What is OnKure Therapeutics, Inc.'s free cash flow?
- After $33.0K of capital expenditures, OnKure Therapeutics, Inc.'s free cash flow was -$50.8M over the trailing twelve months, up 6.9% year over year.
- Where does OnKure Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from OnKure Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.